Suits Claim Drug Maker, APA Plotted To Boost Ritalin

By Jessica Portner

Lawyers filed two class actions last week against the company that makes Ritalin and the American Psychiatric Association, charging both with conspiring to expand the market for the drug used to treat millions of children with attention deficit hyperactivity disorder. One suit was filed in federal court in California, the other in a...

This article is available to subscribers only.

To keep reading this article and more, subscribe now or purchase this article.

Already have an account? Please login.

Subscribe to Education Week and Save

Get a full year and save up to 45%!

Premium Online + Print

37 issues + Online Access
$89

You Save 45%

SUBSCRIBE NOW

(See details.)

Premium Online

12 Months Online Access
$74

You Save 38%

SUBSCRIBE NOW

(See details.)

Most Popular Stories

Viewed

Emailed

Recommended

Commented

Sponsored Whitepapers

• E-Policy Essentials for Schools, Write a Definitive Acceptable Use Policy

• Math Intervention - From Best Practice to Next Practice

• Motivation & Personalization: Middle School Math

• Teaching Self-Regulation Skills to Close the Income-Based Achievement Gap

• Can response systems improve learning outcomes?

• Unique Challenges Facing K-12 IT Professionals

• 10 Steps for Migrating Curriculum to Common Core

• The Educational Promise of Social Media

• Broad Knowledge Drives Literacy

• Using Collaboration to Impact Teaching & Learning

• Data Systems That Help Schools Make a Difference

• Great Books Programs Fit the CCSS

MORE EDUCATION JOBS >>
Post a Job >>